Judit Laszy

Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents

István Gyertyán, Béla Kiss, Katalin Sághy et al. · Neurochemistry International · 2011 · 144 citations

D3 Receptors, Psychiatry, Medicine +8

Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats

Judit Laszy, I. Laszlovszky, István Gyertyán · Psychopharmacology · 2004 · 127 citations

Cognitive Science, Neuropsychology, Brain Function +11

Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors

Éva Ágai-Csongor, György Domány, Katalin Nógrádi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 89 citations · Full text

Medicinal Chemistry, Dopamine D3/d2 Receptors, Psychoactive Drug +8

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15

István Gyertyán, Katalin Sághy, Judit Laszy et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 55 citations

Behavioral Sciences, Psychiatry, Behavioral Neuroscience +15

Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity

Andreas Gravius, Judit Laszy, M. Pietraszek et al. · Behavioural Pharmacology · 2011 · 41 citations

Neuropsychology, Scopolamine-induced Deficit, Psychopharmacology +18